tiprankstipranks
Trending News
More News >
Ercros SA (ES:ECR)
:ECR

Ercros SA (ECR) Price & Analysis

Compare
4 Followers

ECR Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

3.47%95.80%
Insiders
3.47%
Mutual Funds
― Other Institutional Investors
95.80% Public Companies and
Individual Investors

ECR FAQ

What was Ercros SA’s price range in the past 12 months?
Ercros SA lowest stock price was €2.67 and its highest was €3.98 in the past 12 months.
    What is Ercros SA’s market cap?
    Ercros SA’s market cap is €275.22M.
      When is Ercros SA’s upcoming earnings report date?
      Ercros SA’s upcoming earnings report date is Jul 23, 2025 which is in 55 days.
        How were Ercros SA’s earnings last quarter?
        Ercros SA released its earnings results on May 13, 2025. The company reported -€0.143 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.143.
          Is Ercros SA overvalued?
          According to Wall Street analysts Ercros SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Ercros SA pay dividends?
            Ercros SA pays a Annually dividend of €0.077 which represents an annual dividend yield of 2.58%. See more information on Ercros SA dividends here
              What is Ercros SA’s EPS estimate?
              Ercros SA’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Ercros SA have?
              Ercros SA has 91,436,195 shares outstanding.
                What happened to Ercros SA’s price movement after its last earnings report?
                Ercros SA reported an EPS of -€0.143 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.328%.
                  Which hedge fund is a major shareholder of Ercros SA?
                  Currently, no hedge funds are holding shares in ES:ECR

                  Ercros SA Stock Smart Score

                  1
                  Underperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -12.50%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -3.31%
                  Trailing 12-Months
                  Asset Growth
                  2.32%
                  Trailing 12-Months

                  Company Description

                  Ercros SA

                  Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers. This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding powders, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing chipboards, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; plugs and switches in the electrical components sector; and household, sanitary, and packaging materials in the textile tanning industry. The Pharmacy division engages in the production of raw materials and intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, calcium and sodium fosfomycin, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Aperam S.A.
                  Fluidra
                  Inditex
                  Telefonica
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis